HealthTech

MFine is not fine. Does healthtech have a recovery plan after layoffs?

Aditi Shrivastava

Supriya Roy

May 25, 2022 | 8 Min Read

The healthtech app, which has raised over $90 million to date, is scrambling to slash costs by reducing its headcount and marketing spends. Company insiders blame an excessive focus on consumer features for its current state. Can a switch to the more lucrative corporate segment halt the decline?

MFine invited a group of journalists to interact with co-founder and chief technology officer Ajit Narayanan on March 22. In a well-appointed boardroom at The Oberoi, Bengaluru, the data-science team of the buzzy healthtech app showed off proprietary algorithms powering its new tool for checking blood pressure and glucose.

Earlier that month, MFine had launched a tool to help users monitor their heart rate and the year before, it introduced a feature to measure oxygen saturation. Updates were basically being rolled out swiftly on the AI-driven platform. The magic, so to speak, wasn’t happening just on the product front. The five-year-old startup was also hiring in numbers, with 40 openings appearing in search results recently.

All the outward signs suggested its ideas and business were clicking and it was sitting on adequate capital, with no cause for concern. At the Oberoi event, Narayanan claimed it had a good runway. “We are not looking to raise funds at the moment,” he told The CapTable then.

The reality was very different.

Corporate

Access unlimited content at a special discounted rate. Trusted by top VC’s and leading organizations, we provide bulk subscriptions for groups of 30+. Contact us for more details

Campus

Top educational institutions have collaborated with us for campus-wide subscriptions. For bulk campus-wide access, please get in touch.

Join our community of 100,000+ top executives, VCs, entrepreneurs, and brightest student minds

Trusted by the best

Karthik Reddy

Blume Ventures

The CapTable brings a refreshing set of insights for us at the Blume team, highlighting stories that bring together the underlying business and founders with that of investors' journeys with these startups. It's an important perspective that very few bring to startup ecosystem enthusiasts.

Latest Articles

Will the cough syrup crisis finally push India to reform drug regulations?

Repeated tragedies from diethylene glycol–laced syrups reveal the cost of regulatory gaps in a booming but weakly monitored market. India can learn from the US response to a similar tragedy in 1937.

Anuj Suvarna

Decoding Meesho’s DRHP: a solid ecommerce story, but does it have a strong public market one?

Meesho filed its DRHP just as it overtook Flipkart to become India’s largest ecommerce platform by order volume. But beyond its well-established ecommerce success, the company’s new bets in logistics, fintech, and content creation still look too early-stage to move the growth needle significantly.

Team Captable

India wants schools to go cashless. But are parents and classrooms ready?

India’s push to digitise school fee payments via UPI is a promising step toward transparency and ease, but faces major infrastructural and behavioural hurdles.

Parvathi Benu

The great IPL valuation reset as consolidation meets regulation

For the first time in its glittering 18-year history, the IPL is learning what maturity looks like, as its valuation dips 11% from a peak of $11.2 billion two years ago. The JioStar merger and RMG crackdown are reshaping the league’s monetisation engine—from speculative to sustainable.

Sohini Mitter

Why your spouse's name on the property deed won't fool the tax authorities

Joint ownership doesn't mean joint taxation. Surprised? Most couples are, until they get a dreaded tax notice explaining that what matters isn’t whose name is on the property, but whose money bought it.

Maulik M

Convinced that The Captable stories and insights
will give you the edge?

Convinced that The Captable stories
and insights will give you the edge?

Subscribe Now

Stories

Explore